
Overview
Background
Professor Simon Cool is Professor of Bioengineering and Director of the UQ Advanced Cell Therapy Manufacturing Initiative in the School of Chemical Engineering at the University of Queensland.
Professor Cool began his scientific career at the University of Queensland more than 20 years ago. He received his BSc (hons) and PhD degrees from the University of Queensland, where he subsequently held a faculty position in the School of Biomedical Sciences. His areas of studies have included age-related changes in the structure of bone and teeth and the extracellular matrix compartment of skeletal tissue that guide stem cell behaviour and wound repair. Professor Cool was invited to join the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore in 2003 as a Principal Investigator. He then joined A*STAR’s Institute of Medical Biology (IMB) in 2008, shortly after its inception, to further his research in regenerative medicine, serving as Senior Principal Investigator of the Glycotherapeutics Group. In October 2020, Professor Cool re-joined the Institute of Molecular and Cell Biology (IMCB) as a Research Director, Glycotherapeutics, where he focused on developing novel glycosaminoglycan biomolecules that enhance wound repair and control adult human mesenchymal stem cell activity.
Professor Cool has 117 patent applications across 26 families with 51 granted in the fields of glycosaminoglycan biochemistry, regenerative medicine and stem cell science. He has more than 150 publications and continues to foster strong strategic collaborations both nationally and internationally with academic and industry groups. He has a strong biomanufacturing and translational focus with experience in taking glycosaminoglycan-based devices through discovery RnD on to pre-clinical and clinical testing. Professor Cool also has an entrepreneurial and licensing background having successfully spun-off some of his technology to a US-based regenerative medicine start-up company, SMC Biotechnology Ltd. Professor Cool holds a Visiting Professor appointment at the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore and an Adjunct Professor (Research) appointment in the Orthopaedic Department at the National University of Singapore (NUS). Prior to his move back to UQ, he previously held the position of Treasurer, Tissue Engineering and Regenerative Medicine International Society, Asia Pacific Chapter (TERMIS-AP) and Treasurer, Stem Cell Society Singapore (SCSS). He also held senior leadership positions in several Singapore-based R&D programmes, notably as Director, Allogeneic Stem Cell Manufacturing (ASTEM) and Theme Leader in Advanced Manufacturing for Biological Materials (AMBM). Prof Cool currently serves on the Editorial Board of the journals Biomaterials, Tissue Engineering and Regenerative Medicine, and is Asia-Pacific Regional Editor for Stem Cells and Development.
Availability
- Professor Simon Cool is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Science (Honours), unknown
- PhD, unknown
Research interests
-
Manufacturing highly-potent stem cells
Developing novel media, assays, and processes to enable the scale-up manufacturing of cell therapy products.
-
Rejuvenation of ageing stem cells
Developing innovative methods to rejuvenate ageing stem cells to generate best-in-class cell banks for therapeutic use.
-
Synthesis of glycosaminoglycans as medical devices
Developing scalable methods to manufacture fully synthetic glycosaminoglycans for use as media additives, biocoatings and medical devices for treating disease, injury or trauma.
-
Modification of stem cells to improve their therapeutic utility
Altering stem cell surfaces to encourage protein binding and drive stem cell fate decisions for improved therapeutic efficacy.
-
Enhanced angiogenesis through glycosaminoglycan administration and medical device formulation
Developing pro-angiogenic microenvironments using novel glycosaminoglycan formulations.
Research impacts
I have over 25 years of leadership in identifying novel heparan sulphate (HS) glycosaminoglycan (GAG) sugars within stem cell niches and repairing tissues. These sugars sequester, protect, hold, and present key growth factors to stem cells. I have successfully used this complexation paradigm to unlock pathways critical to stem cell biology, mainly signalling cascades essential for maintaining naïve phenotypes. I have also shown that this strategy effectively develops bioadditives for manufacturing cell therapy devices for treating vascular ischemia/stroke, cartilage regeneration, and bone repair. A significant part of this pioneering effort has been manufacturing HS variants that mimic sugars in native tissues. Anchoring this strategy is my novel discovery platform that identifies specific domains in HS chains that form complexes with growth factors and growth factor receptors to generate powerful signalling complexes that mediate cell-fate decisions and potentiate tissue regeneration. Using this blueprint, I have developed a library of bio-inspired HS variants and subjected them to structure/function analyses. I strongly advocate for the safety/tolerability testing of HS materials and continue to lead industry-based projects in this area. I have considerable experience leading outcome-focused multidisciplinary research teams across all scientific discovery and translation aspects, with a proven track record in developing transformative technology and biotechnology entrepreneurship. I lead a long-standing effort to bank mesenchymal stem cells cultured in HS-supplemented media to treat age-related diseases (pre-clinical stage only) and have been working to transition this project to a commercial facility to develop suitable manufacturing and banking protocols for future clinical testing. Through these various opportunities, I have mentored numerous PhD students in Australia, Singapore, and the UK, which has helped accelerate research opportunities and led to significant gains in generating novel findings.
Works
Search Professor Simon Cool’s works on UQ eSpace
2005
Conference Publication
Electrospun polycaprolactone fiber membranes for the sustained delivery of heparin
Luong-Van, E. K., Grondahl, L., Chua, K.B., Leong, K.C., Nurcombe, V. and Cool, S. M. (2005). Electrospun polycaprolactone fiber membranes for the sustained delivery of heparin. Indo-Australian Conference on Biomaterials, Implantable Devicg, India, Jan, 2005.
2005
Journal Article
Adult CNS explants as a source of neural progenitors
Chipperfield, H, Cool, SM, Bedi, K and Nurcombe, V (2005). Adult CNS explants as a source of neural progenitors. Brain Research Protocols, 14 (3), 146-153. doi: 10.1016/j.brainresport.2004.12.003
2005
Conference Publication
Response of osteoblast cells to the surface properties of Poly(3-hydroxybutyrate-co-hydroxyvalerate) PHBV
Keen, I., Raggatt, L., Cool, S. M., Nurcombe, V., Fredericks, P., Trau, M. and Grondahl, L. (2005). Response of osteoblast cells to the surface properties of Poly(3-hydroxybutyrate-co-hydroxyvalerate) PHBV. 2nd ARC Centre For Functional Nanomaterials Annual Conference, Maroochydore, Nov, 2005.
2005
Conference Publication
Parathyroid hormone stimulation of Syndecan-4 in osteoblastic cells
Raggatt, J. L., Qin, L., Cool, S. M., Nurcombe, V. and Partridge N. C. (2005). Parathyroid hormone stimulation of Syndecan-4 in osteoblastic cells. 27th Annual Meeting of the American Society for Bone and Mineral Research, Nashville, TN USA, 24-26 September, 2005. Malden, MA USA: American Society for Bone and Mineral Research.
2004
Journal Article
Temporal expression of fibroblast growth factor receptors during primary ligament repair
Cool, Simon M., Synman, Charles P., Nurcombe, Victor and Forwood, Mark (2004). Temporal expression of fibroblast growth factor receptors during primary ligament repair. Knee Surgery Sports Traumatology Arthroscopy, 12 (5), 490-496. doi: 10.1007/s00167-003-0444-x
2004
Journal Article
The development of heparan sulfate sugars as therapeutics: Versatility that couples stem cells, tissue engineering, and wound repair
Nurcombe, Victor, Kumarasuriyar, Arjuna and Cool, Simon M. (2004). The development of heparan sulfate sugars as therapeutics: Versatility that couples stem cells, tissue engineering, and wound repair. Drug Development Research, 62 (4), 303-316. doi: 10.1002/ddr.10395
2004
Journal Article
Functional maturation of isolated neural progenitor cells from the adult rat hippocampus
Hogg, R. C., Chipperfield, H., Whyte, K. A., Stafford, M. R., Hansen, M. A., Cool, S. M., Nurcombe, V. and Adams, D. J. (2004). Functional maturation of isolated neural progenitor cells from the adult rat hippocampus. European Journal of Neuroscience, 19 (9), 2410-2420. doi: 10.1111/j.0953-816X.2004.03346.x
2004
Conference Publication
In vitro analysis of a bioactive, biodegradable material for bone repair
Kumarasuriyar, A., Jackson, R., Grondahl, L., Trau, M., Nurcombe, V. and Cool, S. M. (2004). In vitro analysis of a bioactive, biodegradable material for bone repair. 7th World Biomaterials Congress, Sydney, May, 2004.
2004
Conference Publication
Influence of solvent on the surface properties of PHBV solvent cast films
Keen, I., Grondahl, L., Raggatt, L., Fredericks, P.M., Nurcombe, V., Trau, M. and Cool, S. M. (2004). Influence of solvent on the surface properties of PHBV solvent cast films. 27th Australasian Polymer Symposium, Adelaide, Nov, 2004.
2004
Conference Publication
Heparan sulfate loaded Poly( -caprolactone) microparticles for bone repair
Luong-Van, E. K., Grondahl, L., Nurcombe, V. and Cool, S. M. (2004). Heparan sulfate loaded Poly( -caprolactone) microparticles for bone repair. 7th World Biomaterials Congress, Sydney, May, 2004.
2004
Conference Publication
Development and in vitro testing of a biodegradable bone scaffold
Grondahl, L., Lutton, C. J., Kenny, B., Cool, S. M., Cassady, A.I. and Trau, M. (2004). Development and in vitro testing of a biodegradable bone scaffold. 7th World Biomaterials Congress, Sydney, May, 2004.
2004
Conference Publication
Surface modification of PHBV for bone tissue engineering
Keen, I., Grondahl, L., Cool, S. M., Nurcombe, V. and Trau, M. (2004). Surface modification of PHBV for bone tissue engineering. 7th World Biomaterials Congress, Sydney, May, 2004.
2004
Conference Publication
Teaching gross anatomy in a PBL-based medical curriculum
Kippers, V., Cool, S. and Aland, R. C. (2004). Teaching gross anatomy in a PBL-based medical curriculum. 16th International Congress of the International Federation of Associations of Anatomists (IFAA 2004): Morphological Sciences as the Basis of New Life Science in the 21st Century, Kyoto International Conference Hall, Kyoto, Japan, 22-27 August 2004. Victoria: Blackwell Publishing Asia.
2003
Conference Publication
Surface modification for PHBV for enhanced biocompatibility
Chandler-Temple, A. F., Grondahl, L., Trau, M., Cool, S. M. and Nurcombe, V. (2003). Surface modification for PHBV for enhanced biocompatibility. 13th Annual Conference of Australian Society for Biomaterials, Brisbane, March, 2003.
2003
Conference Publication
Biodegradable polyester materials: Uses in bone regeneration
Grondahl, L., Chandler-Temple, A. F., Luong-Van, E. K., Riding, A. S., Kumarasuriyar, A., Kenny, B., Cool, S. M., Nurcombe, V., Whittaker, A. K., Cassady, I.A. and Trau, M. (2003). Biodegradable polyester materials: Uses in bone regeneration. 26th Australian Polymer Conference, Noosa, July, 2003.
2002
Journal Article
Comparisons between bone and cementum compositions and the possible basis for their layered appearances
Cool, S. M., Forwood, M. R., Campbell, P. and Bennett, M. B. (2002). Comparisons between bone and cementum compositions and the possible basis for their layered appearances. Bone, 30 (2), 386-392. doi: 10.1016/S8756-3282(01)00686-X
2002
Journal Article
Heparan sulfates isolated from adult neural progenitor cells can direct phenotypic maturation
Chipperfield, H., Bedi, K. S., Cool, S. M. and Nurcombe, V. (2002). Heparan sulfates isolated from adult neural progenitor cells can direct phenotypic maturation. International Journal of Developmental Biology, 46 (4), 1-6.
2002
Journal Article
Temporal and spatial expression of fibroblast growth factor receptor 4 isoforms in murine tissues
Cool, S. M., Sayer, R. E., van Heumen, W. R., Pickles, J. O. and Nurcombe, V. (2002). Temporal and spatial expression of fibroblast growth factor receptor 4 isoforms in murine tissues. Histochemical Journal, 34 (6-7), 291-297. doi: 10.1023/A:1023326524562
2002
Journal Article
Fibroblast growth factor receptor 4 (FGFR4) expression in newborn murine calvaria and primary osteoblast cultures
Cool, S, Jackson, R, Pincus, P, Dickinson, I and Nurcombe, V (2002). Fibroblast growth factor receptor 4 (FGFR4) expression in newborn murine calvaria and primary osteoblast cultures. International Journal of Developmental Biology, 46 (4), 519-523.
2001
Journal Article
Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways
Descamps, S, Toillon, RA, Adriaenssens, E, Pawlowski, V, Cool, SM, Nurcombe, V, Le Bourhis, XF, Boilly, B, Peyrat, JP and Hondermarck, H (2001). Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. Journal of Biological Chemistry, 276 (21), 17864-17870. doi: 10.1074/jbc.M010499200
Funding
Past funding
Supervision
Availability
- Professor Simon Cool is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Orthopaedic application of glycotherapeutics linked to implantable scaffolds
We have developed a range of glycosaminoglycan compounds that drive cell fate decisions through complexation with protein/protein receptors that are important for bone formation. Here we seek to coat implantable scaffolds (doi: 10.1116/1.4933109) with these materials and to progress these implantable orthopaedic devices through a range of preclinical models in an effort to define their future clinical utility.
-
Age-related changes in stem cell glycosaminoglycans
We have identified a range of glycosaminoglycan-altering enzymes that can potentially drive senescent phenotypes linked to stem cell ageing during scale-up manufacturing. Here we seek to develop glycosaminoglycan variants capable of replenishing these lost glycosaminoglycan structures that can restore growth and potency.
Supervision history
Current supervision
-
Doctor Philosophy
Elucidating the effects of potency biomarkers on cellular reprogramming and differentiation in adult stem cells
Principal Advisor
Other advisors: Professor Nathan Palpant, Dr Alex Smith
-
Doctor Philosophy
Fabrication of sulfated alginate nano-particles for protein delivery
Associate Advisor
Other advisors: Professor Lisbeth Grondahl, Dr Ali Shokoohmand
-
Doctor Philosophy
Understanding the role of electrical fields on cell fates
Associate Advisor
Other advisors: Professor Justin Cooper-White
-
Doctor Philosophy
Regenerative engineering solutions for rotator cuff repair using stem cells and bioactives
Associate Advisor
Other advisors: Professor Lisbeth Grondahl, Professor Justin Cooper-White
Completed supervision
-
-
2009
Doctor Philosophy
Heparan sulphate releasing biomaterials for tissue engineering
Principal Advisor
Other advisors: Professor Lisbeth Grondahl
-
2005
Doctor Philosophy
AUGMENTING OSTEOGENESIS THROUGH CHEMICAL AND MECHANICAL STIMULATION: THE USE OF LOADING AND HEPARAN SULFATE TO ENHANCE IN VITRO AND IN VIVO BONE FORMATION
Principal Advisor
-
2008
Doctor Philosophy
THE NOVEL ISOLATION OF HEPARAN SULFATE WITH A SPECIFIC AFFINITY FOR BONE MORPHOGENTIC PROTEIN 2
Associate Advisor
Other advisors: Associate Professor Peter Noakes
Media
Enquiries
For media enquiries about Professor Simon Cool's areas of expertise, story ideas and help finding experts, contact our Media team: